BMRN
Biomarin Pharmaceutical Inc
Price:  
55.24 
USD
Volume:  
2,309,678.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biomarin Intrinsic Value

51.80 %
Upside

What is the intrinsic value of Biomarin?

As of 2025-06-20, the Intrinsic Value of Biomarin Pharmaceutical Inc (BMRN) is 83.86 USD. This Biomarin valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 55.24 USD, the upside of Biomarin Pharmaceutical Inc is 51.80%.

The range of the Intrinsic Value is 53.32 - 225.02 USD

Is Biomarin undervalued or overvalued?

Based on its market price of 55.24 USD and our intrinsic valuation, Biomarin Pharmaceutical Inc (BMRN) is undervalued by 51.80%.

55.24 USD
Stock Price
83.86 USD
Intrinsic Value
Intrinsic Value Details

Biomarin Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) 53.32 - 225.02 83.86 51.8%
DCF (Growth 10y) 72.12 - 293.72 111.76 102.3%
DCF (EBITDA 5y) 56.22 - 76.56 67.76 22.7%
DCF (EBITDA 10y) 70.67 - 100.09 86.24 56.1%
Fair Value 68.29 - 68.29 68.29 23.63%
P/E 48.24 - 70.18 58.71 6.3%
EV/EBITDA 49.64 - 65.06 58.15 5.3%
EPV 20.06 - 25.90 22.98 -58.4%
DDM - Stable 35.66 - 197.17 116.42 110.7%
DDM - Multi 58.28 - 252.39 94.92 71.8%

Biomarin Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 10,593.93
Beta 0.52
Outstanding shares (mil) 191.78
Enterprise Value (mil) 10,140.77
Market risk premium 4.60%
Cost of Equity 7.30%
Cost of Debt 4.25%
WACC 7.12%